Literature DB >> 10442342

Management of brain metastases.

P Y Wen1, J S Loeffler.   

Abstract

Brain metastases are the most common type of brain tumor in adults and are an increasingly important cause of morbidity and mortality in cancer patients. In recent years, important advances have been made in the diagnosis and management of brain metastases. These advances include the widespread use of magnetic resonance imaging (MRI), enabling small metastases to be detected; the introduction of stereotactic radiosurgery; and the performance of studies that have clarified the role of surgery and postoperative radiation therapy for single brain metastases. As a result, most patients receive effective palliation, and the majority do not die from their brain metastases. However, further studies are needed to define the optimal role of conventional treatments and to develop more effective novel therapies.

Entities:  

Mesh:

Year:  1999        PMID: 10442342

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  41 in total

1.  Metastatic lung disease to the central nervous system: in vitro response to chemotherapeutic agents.

Authors:  Jane W Marsh; Maryann Donovan; Dennis R Burholt; Lisa D George; Paul L Kornblith
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

2.  A plea for the elective inclusion of the brain in routine whole-body FDG PET.

Authors:  Tarik Belhocine; Stefan Markus Weiner; Ingo Brink; Peter Paul De Deyn; Jan Roland; Thierry Van der Borght; Patrick Flamen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

Review 3.  Current management of metastatic brain disease.

Authors:  Tulika Ranjan; Lauren E Abrey
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 4.  Current approaches to the treatment of metastatic brain tumours.

Authors:  Taofeek K Owonikoko; Jack Arbiser; Amelia Zelnak; Hui-Kuo G Shu; Hyunsuk Shim; Adam M Robin; Steven N Kalkanis; Timothy G Whitsett; Bodour Salhia; Nhan L Tran; Timothy Ryken; Michael K Moore; Kathleen M Egan; Jeffrey J Olson
Journal:  Nat Rev Clin Oncol       Date:  2014-02-25       Impact factor: 66.675

5.  Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases.

Authors:  Kamran A Ahmed; Jessica M Freilich; Yazan Abuodeh; Nicholas Figura; Neha Patel; Siriporn Sarangkasiri; Prakash Chinnaiyan; Hsiang-Hsuan Michael Yu; Arnold B Etame; Nikhil G Rao
Journal:  J Neurooncol       Date:  2014-03-07       Impact factor: 4.130

Review 6.  Modern multidisciplinary management of brain metastases.

Authors:  Sajeve S Thomas; Erin M Dunbar
Journal:  Curr Oncol Rep       Date:  2010-01       Impact factor: 5.075

Review 7.  Brain metastases: treatment options to improve outcomes.

Authors:  Phillip Davey
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

8.  Use of liposomal doxorubicin-cyclophosphamide combination in breast cancer patients with brain metastases: a monocentric retrospective study.

Authors:  B Linot; M Campone; P Augereau; R Delva; S Abadie-Lacourtoisie; N Nebout-Mesgouez; O Capitain
Journal:  J Neurooncol       Date:  2014-01-31       Impact factor: 4.130

9.  Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis.

Authors:  Feng-Ju Huang; Patricia S Steeg; Janet E Price; Wen-Tai Chiu; Ping-Chieh Chou; Keping Xie; Raymond Sawaya; Suyun Huang
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

10.  Immunoexpression of endoglin in brain metastasis secondary to malignant melanoma: evaluation of angiogenesis and comparison with brain metastasis secondary to breast and lung carcinomas.

Authors:  Karina B Salgado; Nadima V Toscani; Leonardo L M Silva; Arlete Hilbig; Ligia Maria Barbosa-Coutinho
Journal:  Clin Exp Metastasis       Date:  2007-06-13       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.